Suchergebnisse - "Mertens, Laura S"

PubPharm (125)

1

A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2024

von Hagens, M. | van Leeuwen, P. | Wondergem, M. | +8

2

Membranous urethral length measurement on preoperative MRI to predict incontinence after radical prostatectomy : a literature review towards a proposal for measurement standardization

enthalten in: European radiology | 2024

von Boellaard, T. | van Dijk-de Haan, M. | Heijmink, S. | +6

CommentIn: Eur Radiol. 2023 Sep 22;:. - PMID 37740087

3

Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer : impact on prognosis?

enthalten in: International urology and nephrology | 2024

von Beijert, I. | Hentschel, A. | Bründl, J. | +64

4

Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer

enthalten in: Journal of clinical medicine | 2024

von Pichler, R. | Stäblein, J. | Mari, A. | +16

5

How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working Group

enthalten in: BJU international | 2024

von Pellegrino, F. | Martini, A. | Falagario, U. | +41

6

Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer : Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31

enthalten in: European urology | 2024

von Alfred Witjes, J. | Bruins, H. | Carrión, A. | +20

ErratumFor: Eur Urol. 2024 Jan;85(1):17-31. - PMID 37858453

7

The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer

enthalten in: BJU international | 2024

von von Deimling, M. | Mertens, L. | Furrer, M. | +40

8

Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer

enthalten in: The Lancet. Oncology | 2024

von Mertens, L. | van der Heijden, M.

9

Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma : A Multicenter Analysis of Oncological Outcomes and Risk Dynamics

enthalten in: European urology oncology | 2024

von Subiela, J. | Krajewski, W. | González-Padilla, D. | +35

10

Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer

enthalten in: BJU international | 2024

von von Deimling, M. | Furrer, M. | Mertens, L. | +40

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]